Serum Neuron-Specific Enolase and S-100B Protein in Cardiac Arrest Patients Treated With Hypothermia
- 1 December 2003
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (12) , 2881-2886
- https://doi.org/10.1161/01.str.0000103320.90706.35
Abstract
Background and Purpose— High serum levels of neuron-specific enolase (NSE) and S-100B protein are known to be associated with ischemic brain injury and poor outcome after cardiac arrest. Therapeuti...Keywords
This publication has 20 references indexed in Scilit:
- Treatment of Comatose Survivors of Out-of-Hospital Cardiac Arrest with Induced HypothermiaNew England Journal of Medicine, 2002
- Mild Therapeutic Hypothermia to Improve the Neurologic Outcome after Cardiac ArrestNew England Journal of Medicine, 2002
- S100B as a predictor of size and outcome of stroke after cardiac surgeryThe Annals of Thoracic Surgery, 2001
- Serum Neuron-specific Enolase as a Prognostic Marker for Irreversible Brain Damage in Comatose Cardiac Arrest SurvivorsAcademic Emergency Medicine, 1996
- The S100 protein family: History, function, and expressionBrain Research Bulletin, 1995
- Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarctionEuropean Journal of Clinical Investigation, 1991
- A Randomized Clinical Study of a Calcium-Entry Blocker (Lidoflazine) in the Treatment of Comatose Survivors of Cardiac ArrestNew England Journal of Medicine, 1991
- Neurone-specific enolase is a molecular marker for peripheral and central neuroendocrine cellsNature, 1978
- Brain Enolases as Specific Markers of Neuronal and Glial CellsScience, 1978
- ASSESSMENT OF OUTCOME AFTER SEVERE BRAIN DAMAGE: A Practical ScalePublished by Elsevier ,1975